News

Dupixent® (Dupilumab) Data At Revolutionizing Atopic Dermatitis (RAD) Conference Reinforce Use In Atopic Dermatitis Patients With Skin Of Color
Atopic dermatitis is a chronic disease that disproportionately impacts communities of color Dupixent achieved ...
WebMD1mon
New Treatment for Chronic Spontaneous Urticaria: An Expert's Insights and Key Facts
How Much Does This Treatment Cost? Will Insurance Cover It? According to the company website, the list price of dupilumab (Dupixent) is $3,993.36 per carton, which is a one-month supply.
Stockhouse2mon
Dupixent® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients with Chronic Obstructive Pulmonary Disease (COPD)
1 Dupilumab is being jointly developed by Regeneron and Sanofi ... competing drugs and product candidates that may be superior to, or more cost effective than, Regeneron’s Products and ...
manilatimes2mon
Dupixent® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients with Chronic Obstructive Pulmonary Disease (COPD)
1 Dupilumab is being jointly developed by Regeneron and Sanofi ... competing drugs and product candidates that may be superior to, or more cost effective than, Regeneron's Products and Regeneron's ...
Morningstar2mon
Dupixent® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients with Chronic Obstructive Pulmonary Disease (COPD)
1 Dupilumab is being jointly developed by Regeneron ... competing drugs and product candidates that may be superior to, or more cost effective than, Regeneron’s Products and Regeneron’s ...
Finanznachrichten3mon
Regeneron Pharmaceuticals, Inc.: Dupixent (dupilumab) sBLA Accepted for FDA Priority Review for the Targeted Treatment of Bullous Pemphigoid (BP)
1 Dupilumab is being jointly developed by Regeneron ... competing drugs and product candidates that may be superior to, or more cost effective than, Regeneron's Products and Regeneron's Product ...
manilatimes3mon
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for the Targeted Treatment of Bullous Pemphigoid (BP)
Dupilumab is being jointly developed by Regeneron and Sanofi ... competing drugs and product candidates that may be superior to, or more cost effective than, Regeneron's Products and Regeneron's ...
The Lancet3mon
Patient in her 70s with COPD and asthma improving significantly since using monoclonal antibody dupilumab
She has watched as Australia's Federal Government has piled the pressure on smokers to stop over the past 20 years, making virtually every indoor and also outdoor public space smoke-free, applying ...
Medical News Today4mon
Does Medicare cover eczema treatment?
Out-of-pocket costs are the costs that Medicare does not ... The Food and Drug Administration (FDA) has approved the biologic drug dupilumab (Dupixent). Doctors prescribe it for people with ...
The Straits Times5mon
Singapore seeing more cases of moderate to severe eczema
However, dupilumab costs around $1,000 per dose and is recommended to be given to adults every fortnight. The prices of JAK inhibitors range from $400 to $1,200 per month, depending on the ...
Medscape6mon
EoE: Which First-Line Treatments Are Most Cost-Effective?
A separate, simplified model compared the biologic dupilumab to PPI and tCS. The primary outcome was the incremental cost-effectiveness ratio (ICER) at 2- and 5-year time horizons. Treatment ...